- PackSize
- 50ug/100ug
- Target
- Triggering receptor expressed on myeloid cells 2
- Reactivity
- Human
- Applications
- ELISA, Bioactivity: FACS, Functional assay, Research in vivo
- Host Species
- Human
- Isotype
- IgG1-kappa
- Conjugate/Modification
- --
- Recommended Dilution Ratio
- --
- Composition
- 0.01M PBS, pH 7.4.
- Purification Process
- Protein A/G purified from cell culture supernatant.
- Purity
- >95% purity as determined by SDS-PAGE.
- storageCondition
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
- Clonality
- Monoclonal
- Clone Number
- --
- Immunogen
- Mammalian Cells
- Alias
- Triggering receptor expressed on myeloid cells 2, Triggering receptor expressed on monocytes 2, TREM-2, TREM2
- Species
- --
- Gene ID-1
- Q9NZC2
- Uniprot
- --
- Background
- Iluzanebart is a human IgG1κ antibody targeting TREM2, a triggering receptor expressed on myeloid cells.<br>• Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma., PMID:38237157<br/>• TREM2, microglia, and Alzheimer's disease., PMID:33516818<br/>• Distinct roles of TREM2 in central nervous system cancers and peripheral cancers., PMID:38788719<br/>• TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration., PMID:37442133<br/>• TREM2, Microglia, and Neurodegenerative Diseases., PMID:28442216<br/>• Microglia and TREM2., PMID:38821351<br/>• TREM2 dependent and independent functions of microglia in Alzheimer's disease., PMID:36564824<br/>• TREM2: A new player in the tumor microenvironment., PMID:36989543<br/>• TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis., PMID:33586673<br/>• How neuroinflammation contributes to neurodegeneration., PMID:27540165<br/>
- Tissue Expression
- --
- Signaling_pathway
- --
- Research Areas
- --